Test score may predict which prostate cancer patients can safely skip combined therapy
Full article:

This study shows that a test score that estimates the aggressiveness of a person’s prostate cancer may also identify the best treatment for patients. (posted 7/9/21)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies enrolling people with early-stage prostate cancer.  

A number of other clinical trials for patients with early-stage prostate can be found here.


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.